Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive
Mast cell leukemia (MCL) is a rare and aggressive disease with poor prognosis and short survival time. D816V c-KIT mutation is the most frequent molecular abnormality and plays a crucial role in the pathogenesis and development of the disease. Thus, comprehensive diagnostic investigations and molecu...
Saved in:
| Main Authors: | Magalie Joris, Sophie Georgin-Lavialle, Marie-Olivia Chandesris, Ludovic Lhermitte, Jean-François Claisse, Danielle Canioni, Katia Hanssens, Gandhi Damaj, Olivier Hermine, Mohammed Hamidou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2012/517546 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Total Tryptase Level Confirms Itself as a More Reliable Marker of Mast Cells Burden in Mast Cell Leukaemia (Aleukaemic Variant)
by: P. Savini, et al.
Published: (2015-01-01) -
Mutational Landscape of <i>KIT</i> Proto-Oncogene Coding Sequence in 62 Canine Cutaneous and Subcutaneous Mast Cell Tumors
by: Ludovica Montanucci, et al.
Published: (2024-11-01) -
Autoimmune Phenomenon Associated With Posttransplant Lymphoproliferative Disorder
by: Pierre Isnard, et al.
Published: (2024-03-01) -
HEMATOLOGICAL MALIGNANCIES. LYMPHOCYTIC LEUKAEMIA
by: Peter F. Litvitsky, et al.
Published: (2016-11-01) -
Bone marrow mast cells and mast cell tryptase in plasma cell disorders
by: Raveena Yadav, et al.
Published: (2025-03-01)